Showing results (51-60 of 390) with videos related to
Sort By:
Pageof 39
The Lancet. Neurology|November 17, 2012
Measurement and clinical effect of grey matter pathology in multiple sclerosisJeroen J G Geurts, Massimiliano Calabrese, Elizabeth Fisher, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2019
Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data setsMarcus W Koch, Jop Mostert, Bernard Uitdehaag, et al.Muscle & Nerve|September 4, 2019
Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysisLinda Harris, Inmaculada B Aban, Haichang Xin, et al.Journal of Clinical Neuromuscular Disease|August 25, 2020
Longitudinal Analysis of Disease Burden in Refractory and Nonrefractory Generalized Myasthenia Gravis in the United StatesLinda Harris, Phillip H Allman, Reinee Sheffield, et al.Annals of Clinical and Translational Neurology|April 17, 2025
Handling rescue therapy in myasthenia gravis clinical trials: why it matters and why you should careJustin M Leach, Inmaculada Aban, Gary Cutter, et al.Neurology|October 28, 2009
A cross-sectional study of bone health in multiple sclerosisRuth Ann Marrie, Gary Cutter, Tuula Tyry, et al.Muscle & Nerve|February 22, 2018
Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registryIkjae Lee, Henry J Kaminski, Haichang Xin, et al.Neuroepidemiology|May 21, 2011
Physical activity and self-reported cardiovascular comorbidities in persons with multiple sclerosis: evidence from a cross-sectional analysisRobert W Motl, Bo Fernhall, Edward McAuley, et al.Journal of Neuroimmunology|September 13, 2002
Sex differences in cytokine responses to myelin peptides in multiple sclerosisClara M Pelfrey, Anne C Cotleur, Jar-Chi Lee, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 10, 2010
Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpointBrian C Healy, David Ikle, Eric A Macklin, et al.Pageof 39